BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23171663)

  • 1. Luteolin inhibits angiotensin II-induced human umbilical vein endothelial cell proliferation and migration through downregulation of Src and Akt phosphorylation.
    Zhu M; Chen D; Li D; Ding H; Zhang T; Xu T; Zhang Y
    Circ J; 2013; 77(3):772-9. PubMed ID: 23171663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin inhibited hydrogen peroxide-induced vascular smooth muscle cells proliferation and migration by suppressing the Src and Akt signalling pathways.
    Lang Y; Chen D; Li D; Zhu M; Xu T; Zhang T; Qian W; Luo Y
    J Pharm Pharmacol; 2012 Apr; 64(4):597-603. PubMed ID: 22420665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High D-glucose alters PI3K and Akt signaling and leads to endothelial cell migration, proliferation and angiogenesis dysfunction].
    Yu P; Yu DM; Qi JC; Wang J; Zhang QM; Zhang JY; Tang YZ; Xing QL; Li MZ
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3425-30. PubMed ID: 17313857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
    Chen YF; Wu S; Li X; Chen M; Liao HF
    Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of BAD.
    Gu Q; Wang D; Wang X; Peng R; Liu J; Jiang T; Wang Z; Wang S; Deng H
    Radiat Res; 2004 Jun; 161(6):692-702. PubMed ID: 15161350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways.
    Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X
    Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells.
    Ding H; Li D; Zhang Y; Zhang T; Zhu H; Xu T; Luo Y; Wang C
    Curr Pharm Biotechnol; 2014; 14(12):1009-15. PubMed ID: 24433500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
    Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
    World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism.
    Cattaneo MG; Lucci G; Vicentini LM
    Exp Cell Res; 2009 Nov; 315(18):3210-9. PubMed ID: 19563802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation.
    Lu J; Xu F; Zhang J
    Hum Cell; 2019 Jul; 32(3):316-325. PubMed ID: 31127489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells.
    Montiel M; de la Blanca EP; Jiménez E
    Biochem Biophys Res Commun; 2005 Feb; 327(4):971-8. PubMed ID: 15652490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan inhibits VEGF- and bFGF-induced vascular endothelial cell migration via downregulation of the PI3K-Akt signaling pathway.
    Nakashio A; Fujita N; Tsuruo T
    Int J Cancer; 2002 Mar; 98(1):36-41. PubMed ID: 11857382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocin Improves the Endothelial Function Regulated by Kca3.1 Through ERK and Akt Signaling Pathways.
    Yang H; Li X; Liu Y; Li X; Li X; Wu M; Lv X; Chunhua C; Ding X; Zhang Y
    Cell Physiol Biochem; 2018; 46(2):765-780. PubMed ID: 29621746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
    Yao X; Jiang W; Yu D; Yan Z
    Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin inhibits the proliferation, adhesion, migration and invasion of choroidal melanoma cells in vitro.
    Shi ML; Chen YF; Wu WQ; Lai Y; Jin Q; Qiu WL; Yu DL; Li YZ; Liao HF
    Exp Eye Res; 2021 Sep; 210():108643. PubMed ID: 34058231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic acid A inhibits angiotensin II-induced proliferation of human umbilical vein endothelial cells by attenuating the production of ROS.
    Yang LL; Li DY; Zhang YB; Zhu MY; Chen D; Xu TD
    Acta Pharmacol Sin; 2012 Jan; 33(1):41-8. PubMed ID: 22101169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.